Global Protein Fractionation Market Size By Type (IS, FLAG), By Application (Infant Formula, Clinical Nutrition), By Region, And Segment Forecasts, 2023 to 2032

lobal Protein Fractionation Market Report Description

The Global Protein Fractionation Market was valued at USD 22.4 billion in 2023 and is projected to reach USD 39.6 billion by 2031, growing at a CAGR of 7.4% during the forecast period (2023–2031).

The rising demand for biopharmaceuticals, advancements in protein purification technologies, and the increasing prevalence of chronic diseases such as cancer, autoimmune disorders, and metabolic diseases are key drivers of this market. Protein fractionation techniques are critical in the development of plasma-derived therapeutics, monoclonal antibodies, and vaccines. Additionally, the growing adoption of personalized medicine and the increasing number of R&D activities in proteomics are further fueling market expansion.

Drivers

Growing Demand for Plasma-Derived Therapeutics

The increasing need for immunoglobulins, albumin, clotting factors, and other plasma-based therapies for treating immune deficiencies, hemophilia, and liver diseases is driving the adoption of advanced protein fractionation processes.

Rising Investments in Biopharmaceutical R&D

Biopharma companies are heavily investing in the discovery and development of protein-based drugs. The need for scalable, high-purity fractionation techniques is growing with the rising production of monoclonal antibodies, vaccines, and biosimilars.

Technological Advancements in Protein Separation

Innovations such as membrane chromatography, continuous purification systems, and single-use technologies are improving fractionation efficiency, reducing costs, and enhancing throughput, making these techniques more accessible.

Restraints

High Equipment and Process Costs

The procurement and maintenance of advanced protein fractionation equipment, along with stringent GMP (Good Manufacturing Practice) requirements, increase operational costs, limiting adoption by small- and medium-scale manufacturers.

Stringent Regulatory Landscape

Protein-based therapeutics require rigorous validation and regulatory approvals, which can delay product launches and restrict market growth, particularly in emerging economies with evolving healthcare frameworks.

Opportunity

Rising Adoption of Personalized Medicine

The growing shift toward precision medicine and targeted therapies creates an increased demand for specialized protein purification techniques to manufacture patient-specific treatments.

Expansion in Emerging Markets

Developing countries in Asia-Pacific and Latin America are seeing rapid healthcare infrastructure growth and rising demand for plasma-derived products, opening new opportunities for protein fractionation technologies.

Integration of AI and Automation in Bioprocessing

The adoption of AI-driven analytics and automated purification systems offers significant potential to enhance production efficiency and reduce errors in large-scale fractionation processes.

Market by System Type Insights

Based on system type, the Chromatography Segment dominated the market in 2023, accounting for the largest share due to its high selectivity and scalability for purifying complex protein mixtures. Meanwhile, Membrane Filtration Systems are expected to witness the fastest growth during the forecast period due to their cost-effectiveness and faster processing times.

Market by End-use Insights

By end-use, the Biopharmaceutical & Biotechnology Companies segment held over 50% of the market share in 2023, driven by the large-scale production of therapeutic proteins. The Research & Academic Institutes segment is also growing significantly due to the increasing focus on proteomics and protein structure analysis.

Market by Regional Insights

North America led the global protein fractionation market in 2023, attributed to a strong biopharmaceutical sector, advanced healthcare infrastructure, and a high prevalence of chronic diseases.

Europe holds a substantial market share, driven by supportive government policies and established plasma fractionation facilities.

Asia-Pacific is projected to register the fastest growth rate, fueled by expanding healthcare access, growing biopharma investments in China and India, and increasing demand for cost-effective therapeutics.

Competitive Scenario

Key players in the Global Protein Fractionation Market include:

Thermo Fisher Scientific Inc.

Merck KGaA

GE Healthcare (Cytiva)

Bio-Rad Laboratories, Inc.

Sartorius AG

Repligen Corporation

Danaher Corporation

Kedrion Biopharma

These companies focus on product innovation, strategic partnerships, mergers & acquisitions, and expansion into emerging markets. For example:

In 2023, Thermo Fisher Scientific launched a next-generation chromatography system to enhance plasma protein purification throughput.

In 2024, Merck KGaA partnered with a leading biotech firm to develop AI-enabled purification workflows for monoclonal antibodies.

In 2025, Cytiva expanded its single-use chromatography solutions portfolio, targeting continuous bioprocessing applications.

Scope of Work – Global Protein Fractionation Market

Key Market Developments

May 2023: Sartorius AG launched an advanced single-use filtration platform for high-throughput protein purification.

August 2024: Repligen Corporation acquired a chromatography technology startup to strengthen its portfolio in plasma protein fractionation.

January 2025: Bio-Rad announced a strategic alliance with a global biopharma company to co-develop continuous fractionation technologies.

FAQs

What is the current market size of the Global Protein Fractionation Market?

The market was valued at USD 22.4 billion in 2023.

What is the major growth driver of the Global Protein Fractionation Market?

The rising demand for plasma-derived therapeutics and advancements in protein purification technologies are the primary growth drivers.

Which is the largest region during the forecast period in the Global Protein Fractionation Market?

North America is expected to remain the leading region due to a robust biopharma sector and high therapeutic demand.

Which segment accounted for the largest market share in the Global Protein Fractionation Market?

The Chromatography Segment dominated the market in 2023.

Who are the key market players in the Global Protein Fractionation Market?

Major players include Thermo Fisher Scientific, Merck KGaA, GE Healthcare, Bio-Rad Laboratories, and Sartorius AG.

Would you like me to also create a visually appealing PDF report format for this market description? Or should I generate a similar report for another market?